These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 1908917)

  • 1. Comparison of cardiovascular effects of a novel class Ic antiarrhythmic agent, NIK-244, with those of flecainide in isolated canine heart preparations cross-circulated with a donor dog.
    Sugiyama A; Motomura S; Hashimoto K
    Jpn J Pharmacol; 1991 May; 56(1):1-12. PubMed ID: 1908917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of cardiovascular effects of pirmenol with those of disopyramide in isolated canine heart preparations cross-circulated with a donor dog.
    Sugiyama A; Motomura S; Tamura K; Hashimoto K
    Jpn J Pharmacol; 1990 May; 53(1):97-110. PubMed ID: 2352380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An electrophysiological comparison of a novel class Ic antiarrhythmic agent, NIK-244 (ethacizin) and flecainide in canine ventricular muscle.
    Satoh H; Ishii M; Hashimoto K
    Br J Pharmacol; 1989 Nov; 98(3):827-32. PubMed ID: 2511994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronotropic, inotropic, dromotropic and coronary vasodilator effects of bisaramil, a new class I antiarrhythmic drug, assessed using canine isolated, blood-perfused heart preparations.
    Haruno A; Sugiyama A; Hashimoto K
    Jpn J Pharmacol; 1999 Jul; 80(3):267-70. PubMed ID: 10461773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of cardiovascular effects of a new calcium channel blocker AH-1058 with those of verapamil assessed in blood-perfused canine heart preparations.
    Takahara A; Sugiyama A; Dohmoto H; Yoshimoto R; Hashimoto K
    J Cardiovasc Pharmacol; 2000 May; 35(5):741-8. PubMed ID: 10813376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular effects of a new phenoxyalkylamine derivative, 2-isopropyl-5-[3-(2-methoxyphenoxy)propylamino]-2-(3,4,5-trimethoxy phenyl) valeronitrile fumarate (HV-525), in cross-circulated dog atrial preparations.
    Chiba S; Ogiwara Y; Furukawa Y; Saegusa K
    Jpn Heart J; 1987 Mar; 28(2):261-72. PubMed ID: 3599413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Negative chronotropic and inotropic effects of class I antiarrhythmic drugs assessed in isolated canine blood-perfused sinoatrial node and papillary muscle preparations.
    Sugiyama A; Takehana S; Kimura R; Hashimoto K
    Heart Vessels; 1999; 14(2):96-103. PubMed ID: 10651186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electrophysiological effects of Org 7797 in the closed-chest anaesthetized dog.
    Leboeuf J; Basiez M; Massingham R
    Br J Pharmacol; 1993 Sep; 110(1):23-8. PubMed ID: 8220882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential modulation of autonomic activity by ethmozin and ethacizin (analog of ethmozin) on the canine sinus node and atrioventricular junction.
    Urthaler F; Rosenshtraukh LV; Hageman GR; Anjukhovsky EP; James TN
    J Am Coll Cardiol; 1986 Jul; 8(1 Suppl A):86A-94A. PubMed ID: 3519734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electrophysiologic effects of flecainide acetate and its major metabolites in the canine heart.
    Guehler J; Gornick CC; Tobler HG; Almquist A; Schmid JR; Benson DW; Benditt DG
    Am J Cardiol; 1985 Mar; 55(6):807-12. PubMed ID: 3919554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Profile of cardiac and coronary vasodilator effects of MS-857, a novel cardiotonic agent, assessed in isolated, blood-perfused heart preparations of the dog.
    Maruyama M; Kamiya J; Kobari T
    J Cardiovasc Pharmacol; 1989 Nov; 14(5):777-82. PubMed ID: 2481193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coronary vasodilator and cardiac effects of NKY-722, a novel hydrophilic 1,4-dihydropyridine derivative, in the blood-perfused dog heart.
    Imagawa J; Satoh K; Taira N
    Cardiovasc Drugs Ther; 1989 Mar; 3(1):81-90. PubMed ID: 2487526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of direct negative chronotropic and positive inotropic effects of sematilide to those of E-4031 and MS-551 and the reverse frequency-dependent prolongation of cardiac refractoriness of sematilide.
    Yamada A; Motomura S; Hashimoto K
    J Cardiovasc Pharmacol; 1996 Jan; 27(1):159-66. PubMed ID: 8656651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardioselective effects of gallopamil compared with verapamil in the dog heart.
    Takahashi K; Tsuchida K; Aihara H
    Arch Int Pharmacodyn Ther; 1988; 295():157-73. PubMed ID: 3245731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inotropic versus chronotropic, dromotropic, and coronary vasodilator actions of DPI 201-106, a novel positive inotropic agent, in the dog heart.
    Takahashi K; Endoh M; Taira N
    J Cardiovasc Pharmacol; 1987 Apr; 9(4):451-60. PubMed ID: 2438508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utilization of an isolated, blood-perfused canine papillary muscle preparation as a model to assess efficacy and adversity of class I antiarrhythmic drugs.
    Sugiyama A; Motomura S; Hashimoto K
    Jpn J Pharmacol; 1994 Nov; 66(3):303-16. PubMed ID: 7869617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electrophysiological and inotropic characterization of a novel class III antiarrhythmic agent, GLG-V-13, in the mammalian heart.
    Fazekas T; Carlsson L; Scherlag BJ; Mabo P; Poty H; Palmer M; Patterson E; Berlin KD; Garrison GL; Lazzara R
    J Cardiovasc Pharmacol; 1996 Aug; 28(2):182-91. PubMed ID: 8856472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular and antiarrhythmic effects of the azulene-1-carboxamidine derivative N1,N1-dimethyl-N2-(2-pyridylmethyl)-5-isopropyl-3, 8-dimethylazulene-1-carboxamidine.
    Saitoh M; Sugiyama A; Hagihara A; Nakazawa T; Hashimoto K
    Arzneimittelforschung; 1997 Jul; 47(7):810-5. PubMed ID: 9272236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular effects of (2RS,3SR)- 2-aminomethyl-2,3,7,8-tetrahydro-2,3,5,8,8-pentamethyl-6H-furo- [2,3-e]indol-7-one hydrochloride (UK-1745), a novel cardiotonic agent with vasodilatory and antiarrhythmic properties.
    Uchida Y; Kawada M; Sawanobori K; Sonoki H; Inoue K; Mizuno K; Itou T; Tabunoki Y; Tsukamoto M; Ohashi Y; Kyotani Y; Shimizu N; Fujii M; Nakamura M
    Arzneimittelforschung; 1998 Mar; 48(3):219-31. PubMed ID: 9553677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of a new antiarrhythmic drug, KW-3407, on canine ventricular arrhythmia models].
    Wu Z; Awaji T; Motomura S; Hashimoto K
    Nihon Yakurigaku Zasshi; 1992 Aug; 100(2):117-26. PubMed ID: 1427497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.